asklepionpharm.com asklepionpharm.com

ASKLEPIONPHARM.COM

Asklepion Pharmaceuticals, LLC -

Asklepion Pharmaceuticals, LLC. Research & Pipeline. Acute Lung Injury Induced by CBP. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Aims to provide treatment options for children with rare diseases. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017.

http://www.asklepionpharm.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ASKLEPIONPHARM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 7 reviews
5 star
0
4 star
4
3 star
3
2 star
0
1 star
0

Hey there! Start your review of asklepionpharm.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

FAVICON PREVIEW

  • asklepionpharm.com

    16x16

  • asklepionpharm.com

    32x32

CONTACTS AT ASKLEPIONPHARM.COM

Infrastructure Technology Solutions

Joel Althoff

1000 ●●●●●Ave E

Ca●●de , IA, 52033

US

1.56●●●●3231
jo●●@infrastructuretech.net

View this contact

Infrastructure Technology Solutions

Joel Althoff

1000 ●●●●●Ave E

Ca●●de , IA, 52033

US

1.56●●●●3231
jo●●@infrastructuretech.net

View this contact

Infrastructure Technology Solutions

Joel Althoff

1000 ●●●●●Ave E

Ca●●de , IA, 52033

US

1.56●●●●3231
jo●●@infrastructuretech.net

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2006 October 04
UPDATED
2013 October 05
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 19

    YEARS

  • 0

    MONTHS

  • 24

    DAYS

NAME SERVERS

1
ns1.nl-tech.com
2
ns2.nl-tech.com
3
ns3.nl-tech.com

REGISTRAR

TLDS, LLC DBA SRSPLUS

TLDS, LLC DBA SRSPLUS

WHOIS : whois.srsplus.com

REFERRED : http://www.srsplus.com

CONTENT

SCORE

6.2

PAGE TITLE
Asklepion Pharmaceuticals, LLC - | asklepionpharm.com Reviews
<META>
DESCRIPTION
Asklepion Pharmaceuticals, LLC. Research & Pipeline. Acute Lung Injury Induced by CBP. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Aims to provide treatment options for children with rare diseases. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017.
<META>
KEYWORDS
1 about us
2 leadership
3 careers
4 news
5 clinical trials
6 clinical trial sites
7 pipeline
8 iv citrulline
9 we are a
10 pediatric rare
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,leadership,careers,news,clinical trials,clinical trial sites,pipeline,iv citrulline,we are a,pediatric rare,disease,pharmaceutical,development company,our passions,our focus,our mission,asklepion pharmaceuticals,is dedicated to,asklepion,linkedin
SERVER
nginx
POWERED BY
PleskLin
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Asklepion Pharmaceuticals, LLC - | asklepionpharm.com Reviews

https://asklepionpharm.com

Asklepion Pharmaceuticals, LLC. Research & Pipeline. Acute Lung Injury Induced by CBP. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Aims to provide treatment options for children with rare diseases. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017.

INTERNAL PAGES

asklepionpharm.com asklepionpharm.com
1

Asklepion Pharmaceuticals, LLC -

http://www.asklepionpharm.com/liverfacts/index.html

Asklepion Pharmaceuticals, LLC. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Read more about the company here. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017. L-citrulline pivotal Phase III trial initiated in July 2016.

2

Executives - Asklepion Pharmaceuticals, LLC

http://www.asklepionpharm.com/corporateteam/index.html

Asklepion Pharmaceuticals, LLC. The Executive Leadership Team. To bring the best. Gary Pasternack, MD, PhD. Chief Executive Officer (C.E.O.). Cholic acid) in the US and Kolbam. Chief Operating Officer and Chief Financial Officer (C.O.O./C.F.O.). Terrance Coyne, MD. Chief Medical Officer (C.M.O.). Gary Pyner, MBA. Director of Commercial Affairs. Director of Regulatory Affairs. Director of Clinical Operations. Elizabeth Monnot-Chase, PhD. Director of CMC, Quality.

3

Asklepion Pharmaceuticals, LLC -

http://www.asklepionpharm.com/links/index.html

Asklepion Pharmaceuticals, LLC. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Read more about the company here. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017. L-citrulline pivotal Phase III trial initiated in July 2016.

4

Asklepion Pharmaceuticals, LLC -

http://www.asklepionpharm.com/news/index.html

Asklepion Pharmaceuticals, LLC. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Read more about the company here. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017. L-citrulline pivotal Phase III trial initiated in July 2016.

5

About Our Company - Asklepion Pharmaceuticals, LLC

http://www.asklepionpharm.com/about/index.html

Asklepion Pharmaceuticals, LLC. Our extraordinary work place. We are a small group of professionals in Baltimore. With dedication and collaboration, we have reached significant milestones as a company. One of our largest milestones was obtaining FDA approval for Cholbam. Cholic acid) oral capsules, an oral treatment indicated for bile acid synthesis defects (all assets related to Cholbam were sold to Retrophin, Inc. 729 E Pratt St., Suite 360, Baltimore, MD 21202.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

OTHER SITES

asklepion.de asklepion.de

Domain Default page

Web Server's Default Page. This page is generated by Plesk. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Plesk. Is a hosting control panel with simple and secure web server and website management tools. It was specially designed to help IT specialists manage web, DNS, mail and other services through a comprehensive and user-friendly GUI. Learn more about Plesk.

asklepion.it asklepion.it

www.asklepion.it registrato con mvmnet.com

Parking www.asklepion.it. Il nostro sito è in fase di costruzione, stiamo lavorando per offrirti la miglior esperienza online. Stai cercando il tuo dominio? Mvmnet by Moviement srl a leading company in Internet Services. Domain registration, webhosting, email, SSL and web security. VPS, Cloud, Dedicated server and much more. Phone: 39 (049) 8179. Fax: 39 (049) 8179 100. Via Savelli, 72 Padova - ITALY.

asklepion.org asklepion.org

This Web site coming soon

If you are the owner of this web site you have not uploaded (or incorrectly uploaded) your web site. For information on uploading your web site using FTP client software or web design software, click here for FTP Upload Information.

asklepion.pl asklepion.pl

Asklepion |

asklepion.wz.cz asklepion.wz.cz

A S K L E P I O N  s

A S K L E P I O N s. r. o. Soukromé ambulantní zdravotnické zařízení. Praha 12, Zárubova 497/33 PSČ 14200. Stránky jsou ve stadiu vzniku a nekompletní - děkujeme za pochopení. Poskytujeme služby v těchto oborech:. MUDr Vojtěch Babánek - tel.241712477. MUDr Ladislav Dusík - tel.241712472. MUDr Vladimír Němec - tel.241717200. MUDrAlice Povolná - tel.241712475. MUDrMarie Zahradníková- tel.241712475. Máme smlouvy s těmito zdravotními pojišťovnami:. 111 - Všeobecná zdravotní pojišťovna. Asklepion - původ názvu.

asklepionpharm.com asklepionpharm.com

Asklepion Pharmaceuticals, LLC -

Asklepion Pharmaceuticals, LLC. Research & Pipeline. Acute Lung Injury Induced by CBP. Welcome to Asklepion Pharmaceuticals. Asklepion is focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options, due to the rarity of their conditions. Aims to provide treatment options for children with rare diseases. Asklepion Pharmaceuticals, LLC announces receipt of Orphan Drug Designation from U.S. FDA. January 9, 2017.

asklepionrestaurant.com asklepionrestaurant.com

Bergama Asklepion Restaurant - "Türk Mutfağının Damak Tadı"

Zengin Menümüz. Asklepion Restaurant' tan Kareler. Helenistik Dönem Kalıntılar. İslamik Dönem Kalıntılar. Atatürk Bulvarı No : 54. 0232 633 42 22. 0232 632 20 06. 0232 633 42 23. 0532 292 94 69. 0542 233 61 07. Kültürün Beşiği Bergama' da "lezzet ustası" ASKLEPİON RESTAURANT info@asklepionrestaurant.com. Düğün and Sünnet Organizyon. Tüm Hakları Asklepion Restaurant ' a aittir. İzinsiz kullanılamaz 2008. 0 535 263 48 98.

asklepionsrl.com asklepionsrl.com

ASKLEPION srl - homepage

12 February 2014 10:35:48.

asklepiontherapy.com asklepiontherapy.com

Asklepion Therapy - By Diana Caprau MD

asklepios-apotheke.de asklepios-apotheke.de

Asklepios Apotheke |

0611 - 95016 400. Kümmert sich persönlich um Ihr Wohlbefinden. Sorgt bei AUMEAS mit Herzblut dafür, dass alles nach Plan läuft. Versorgt Sie mit aktuellen Gesundheitsinformationen und Angeboten. Fühlt sich persönlich verantwortlich für Ihre individualisierte Arzneimitteltherapie. Unsere Apotheke ist geöffnet:. 800 - 19.00 Uhr. 830 - 14.00 Uhr. Schiersteiner Str. 42. Telefon: 0611 - 95016 400. Telefax: 0611 - 95016 499. Schreiben Sie uns eine Nachricht:.

asklepios-consulting.com asklepios-consulting.com

ASKLEPIOS CONSULTING

SIE BEHANDELN IHRE PATIENTEN,. WIR ORGANISIEREN DEN REST. Vertretungsberechtigter Geschäftsführer: Marcus Fox. Richardstr. 73 47445 Moers. Tel: 49 (0) 28 41-90 80 6-799. Fax: 49 (0) 28 41-90 80 6-89. Registergericht: Kleve Registernummer: HRB 12964. Umsatzsteuer-Identifikationsnummer gemäß 27a Umsatzsteuergesetz: DE295917566. Haftungshinweis: Trotz sorgfältiger inhaltlicher Kontrolle übernehmen wir keine Haftung für die Inhalte externer Links.